Thursday, March 19, 2020 6:07:15 AM
All this stuff is new to me.
What I believe is most of us simply are seeking the truth.
medchem is a truth seeker.
The post by another poster was misleading the way it was posted here.
It gave the impression Algernon was entering a Phase 3 trial.
I though the exact same thing at first glance,
Until I went to the actual link and read through the sourced information.
From what I could tell the Phase 3 was for another company on the list.
However, that does not mean Algernon will not enter into a Phase 3 trial.
I simply don't know.
What I do know is whether it's a Phase 2 or Phase 3 doesn't matter.
The point is getting drugs into consenting patients and getting positive results.
We must keep in mind Algernon has a global strategy.
Algernon unleashed a blitz of news releases (March 16,2020) in 11 different languages across Asia.
My take on that is Algernon has the drugs necessary to conduct trials throughout Asia and/or USA.
Dr. Mark Williams explains the clinical trial(s) pathway in the BioPub video.
See BioPub video at 12:50 to 18:30 min/sec mark:
The bottom line is we need to know if NP-120 (Ifenprodil) can help.
Whether it's through US FDA or Asia, the goal is to get results now versus later.
The FDA is not Algernon's target audience. Algernon's target audience is Big Pharma.
But let us be clear, Algernon IS coming to the aid of All of Mankind.
ALGERNAUTS
/////AMG
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM